Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids

H.M. Oetter
CMAJ April 03, 2017 189 (13) E508; DOI: https://doi.org/10.1503/cmaj.732899
H.M. Oetter
Registrar and CEO, College of Physicians and Surgeons of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The college would like to address several inaccuracies in a commentary that appeared in CMAJ in December 2016.1

The following statement reflects confusion about two separate events:

There is already preliminary evidence that in British Columbia, where the CDC [US Centers for Disease Control and Prevention] guideline recommendations have been adopted as standards of practice, some patients have sought illicit opioids in the wake of reduced prescribing by physicians.

The college never “adopted” the CDC guideline2 as standards of practice. In April 2016, the college board “endorsed” the principles contained in it, and directed that the college review and update its own Prescribing Principles for Chronic Non-Cancer Pain based on the 12 recommendations contained in the CDC guideline.3

On June 1, 2016, the college board officially replaced Prescribing Principles with a new professional standard titled, Safe Prescribing of Drugs with Potential for Misuse/Diversion (www.cpsbc.ca/files/pdf/2016-06-01-Board-Adopts-New-Standard-on-Safe-Prescribing.pdf). Although many of the principles reflect the CDC guidelines, the college’s standard addresses broader issues of safe prescribing across many drug classes and diagnoses, not just opioids.

All of the principles contained in the standard were deliberately written in general terms, allowing flexibility so that physicians can use their own bedside clinical judgment, and determine the best course of action for their patients. Nothing in the standard prohibits — or even materially interferes with — the ability of pain specialists or other physicians to safely and effectively care for their patients. The standard reinforces the fact that physicians need to be accountable — both to the patient and society at large — for the prescriptions they write. The standard endorses an empathetic discussion between physician and patient of benefits versus harms of long-term prescription medications.

The college is unaware of any incident where a patient has sought illicit opioids as a result of a physician’s reduced prescribing, and suggests it is irresponsible of the authors to make such a claim and to reference a CBC News article as the source of this “preliminary evidence.” The standard does not direct that physicians refrain from prescribing opioids, or stop prescribing opioids immediately. Rather, it clearly guides physicians to taper opioids slowly, when appropriate, in order to minimize symptoms of withdrawal.

Although the college’s professional standard on safe prescribing is legally enforceable under the Health Professions Act, the college prefers to take a remedial approach if it has concerns about a physician’s prescribing patterns. No physician has ever been disciplined or fined for writing a prescription that exceeds a recommended dose. Now more than ever, physicians are being called upon to critically analyze their medication regimens for patients with chronic noncancer pain and other complex patients, and to exercise judicious, safe prescribing.

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Busse JW,
    2. Juurlink D,
    3. Guyatt GH
    . Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain. CMAJ 2016; 188:1210–1.
    OpenUrlFREE Full Text
  2. ↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R
    . CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recomm Rep 2016; 65:1–49.
    OpenUrlCrossRefPubMed
  3. ↵
    College Board endorses the US Centers for Disease Control and Prevention’s Guidelines for Prescribing Opioids for Chronic Pain [media release]. Vancouver: College of Physicians and Surgeons of British Columbia; 2015 Apr. 5. Available: https://www.cpsbc.ca/files/pdf/2016-04-05-Board-Endorses-CDC-Opioid-Guidelines.pdf (accessed 2017 Feb. 21).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (13)
CMAJ
Vol. 189, Issue 13
3 Apr 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids
H.M. Oetter
CMAJ Apr 2017, 189 (13) E508; DOI: 10.1503/cmaj.732899

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids
H.M. Oetter
CMAJ Apr 2017, 189 (13) E508; DOI: 10.1503/cmaj.732899
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain
  • Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”
  • PubMed
  • Google Scholar

Cited By...

  • Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study
  • Response to "Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids"
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
  • Pitfalls of analyzing perinatal outcomes by health care provider
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire